当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析 - 现金流量表

泽璟制药-U

(688266)

  

流通市值:283.77亿  总市值:283.77亿
流通股本:2.65亿   总股本:2.65亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金384,677,977.23193,163,300.7548,643,541.75391,991,532.14
  收到的税费返还---10,475.88
  收到其他与经营活动有关的现金90,465,216.6423,618,133.09324,185,470.57310,862,026.34
  经营活动现金流入小计475,143,193.87216,781,433.79872,829,012.32702,864,034.36
  购买商品、接受劳务支付的现金13,814,093.576,948,762.6355,730,803.7747,672,510.37
  支付给职工以及为职工支付的现金176,226,028.998,927,141.04306,919,736.08237,535,422.87
  支付的各项税费31,750,901.9512,528,233.3651,238,477.0340,182,246.97
  支付其他与经营活动有关的现金270,372,445.53104,630,449.18420,735,450.65310,826,783.58
  经营活动现金流出小计492,163,469.95223,034,586.21834,624,467.53636,216,963.79
  经营活动产生的现金流量净额-17,020,276.08-6,253,152.4238,204,544.7966,647,070.57
二、投资活动产生的现金流量:
  收回投资收到的现金17,179,2007,177,4001,202,227,2001,012,195,200
  取得投资收益收到的现金194,000-14,861,369.194,670,622.15
  投资活动现金流入小计17,373,2007,177,4001,217,088,569.191,016,865,822.15
  购建固定资产、无形资产和其他长期资产支付的现金79,715,800.3633,808,123.1295,690,254.865,410,550.44
  投资支付的现金--2,966,499,701.53943,000,000
  投资活动现金流出小计79,715,800.3633,808,123.123,062,189,956.331,008,410,550.44
  投资活动产生的现金流量净额-62,342,600.36-26,630,723.12-1,845,101,387.148,455,271.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金--339,648.68-
  取得借款收到的现金431,521,145.08141,321,903.341,288,278,854.92798,000,000
  筹资活动现金流入小计431,521,145.08141,321,903.341,288,618,503.6798,000,000
  偿还债务支付的现金317,070,075.83162,000,0001,134,800,000762,800,000
  分配股利、利润或偿付利息支付的现金12,721,068.856,297,303.4124,563,574.9118,707,341.66
  支付其他与筹资活动有关的现金75,817,164.914,820,707.87180,571,344.2394,618,225.53
  筹资活动现金流出小计405,608,309.59173,118,011.281,339,934,919.14876,125,567.19
  筹资活动产生的现金流量净额25,912,835.49-31,796,107.94-51,316,415.54-78,125,567.19
四、汇率变动对现金及现金等价物的影响-453,654.23-9,211.92-2,298,440.51-536,724.67
五、现金及现金等价物净增加额-53,903,695.18-64,689,195.4-1,860,511,698.4-3,559,949.58
  加:期初现金及现金等价物余额217,265,493.08217,265,493.082,077,777,191.482,077,777,191.48
  期末现金及现金等价物余额163,361,797.9152,576,297.68217,265,493.082,074,217,241.9
补充资料:
  净利润-75,569,945.5--150,298,322.91-
  资产减值准备3,358,109.26---
  固定资产和投资性房地产折旧12,070,051.42-22,439,936.01-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,070,051.42-22,439,936.01-
  无形资产摊销9,399,847.16-20,824,367.21-
  长期待摊费用摊销2,869,292.11-5,727,001.74-
  处置固定资产、无形资产和其他长期资产的损失-810.44---
  公允价值变动损失---3,919,137.25-
  财务费用-13,409,228.02--22,550,549.39-
  投资损失-800,771.56--2,939,351.7-
  递延所得税-2,009,690.11--3,881,518.13-
    递延所得税负债增加-2,009,690.11--3,881,518.13-
  存货的减少-15,287,856.49--72,008,791.43-
  经营性应收项目的减少-39,844,818.4--58,167,052.89-
  经营性应付项目的增加85,177,377.53-285,266,612.13-
  其他10,828,754.36-1,617,266.48-
  不涉及现金收支的投资和筹资活动金额其他项目--70,925,241.9-
  现金的期末余额163,361,797.9-217,265,493.08-
  减:现金的期初余额217,265,493.08-2,077,777,191.48-
  现金及现金等价物的净增加额-53,903,695.18--1,860,511,698.4-
公告日期2025-08-232025-04-192025-04-192024-10-26
审计意见(境内)标准无保留意见
TOP↑